succinylestriol Report issue

Small molecule Experimental
AACT ChEMBL DrugBank Drug Central KEGG MeSH PubChem

Active Ingredient History

NOW
  • Now

Chemistry

  • SMILES: C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1C[C@@H](O)[C@@H]2O
  • InChIKey: PROQIPRRNZUXQM-ZXXIGWHRSA-N
  • Mol. Mass: 288.39
  • ALogP: 2.58
  • ChEMBL Molecule:
    estriol  
More Chemistry

Pharmacology

Alternative names

1,3,5(10)-estratriene-3,16-alpha,17beta-triol | (16alpha,17beta)-estra-1,3,5(10)-triene-3,16,17-triol | 16-alpha-hydroxyestradiol | 16alpha-hydroxyestradiol | (16α,17β)-estra-1,3,5(10)-triene-3,16,17-triol | 16α-hydroxyestradiol | 3,16alpha,17beta-trihydroxy-delta(1,3,5)-estratriene | destriol | deuslon-a | estratriol | estriel | estriol | estriol-16,17-dihemisuccinate | estriol acetate benzoate | estriol propionate | estriol succinate | estriol succinate disodium | estriol succinate disodium salt | estriol succinate, disodium salt | estriol succinate sodium | gynest | oestriol | ortho-gynest | ovestin | ovestrion | stiptanon | styptanon | succinylestriol | synapause | theelol | trihydroxyestrin

Organizations (41)

Research & Development (41)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (15)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (15)


 

Atrophic Vaginitis (Phase 3)

Dyspareunia (Phase 1)

Endometrial Hyperplasia (Phase 4)

Epistaxis (Phase 2)

Menopause (Phase 2)

Multiple Sclerosis (Phase 2/Phase 3)

Multiple Sclerosis, Chronic Progressive (Phase 2)

Multiple Sclerosis, Relapsing-Remitting (Phase 2)

Pelvic Organ Prolapse (Phase 4)

Prolapse (Phase 4)

Sexual Dysfunction, Physiological (Phase 1)

Telangiectasia, Hereditary Hemorrhagic (Phase 2)

Urinary Bladder, Neurogenic (Phase 2/Phase 3)

Vaginal Diseases (Phase 4)

Vaginitis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 16
  • # of Trial Organizations: 41

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue